ACD or acid citrate dextrose is a solution of sodium citrate, citric acid and dextrose in water which is primarily used as an anticoagulant to preserve blood specimen. ACD tubes are specialized tubes utilized to preserve the whole blood specimen for future testing purpose. There are several types of acid citrate dextrose tubes available in the market. ACD tubes are primarily utilized in hospitals, clinics and diagnostics centers worldwide.
Geographically, North America and Europe contribute to the maximum share for ACD tubes owing to increasing awareness for safe blood storage, blood transfusion, rise in geriatric population and better health care standards. These regions have better reach to technological advancements and can invest resources in procuring the best health care solutions. Over the forecast period Asia Pacific region is expected to have the fastest growth for these devices due increase in public and private health care expenditure to meet global standards coupled with increase in awareness about hygiene factors in blood transfusion and blood preservation is a major driver in Asia-pacific region. Technological advancements and increase in health care spending will reduce the affordability constraint and further accelerate the adoption of ACD tubes across health care facilities, diagnostic centers and clinics in Latin America, the Middle East and Africa.
The global Acid Citrate Dextrose (ACD) Tubes market was valued at US$ million in 2020 and is expected to reach US$ million by the end of 2027, growing at a CAGR of % during 2021-2027.
This report focuses on Acid Citrate Dextrose (ACD) Tubes volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Acid Citrate Dextrose (ACD) Tubes market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Acid Citrate Dextrose (ACD) Tubes Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
6.0 mL
8.5 mL
Segment by Application
Hospitals
Diagnostics Centers
Health Care Clinics
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Fisher Scientific UK
Becton Dickinson
Cryoquip LLC.
Geographically, North America and Europe contribute to the maximum share for ACD tubes owing to increasing awareness for safe blood storage, blood transfusion, rise in geriatric population and better health care standards. These regions have better reach to technological advancements and can invest resources in procuring the best health care solutions. Over the forecast period Asia Pacific region is expected to have the fastest growth for these devices due increase in public and private health care expenditure to meet global standards coupled with increase in awareness about hygiene factors in blood transfusion and blood preservation is a major driver in Asia-pacific region. Technological advancements and increase in health care spending will reduce the affordability constraint and further accelerate the adoption of ACD tubes across health care facilities, diagnostic centers and clinics in Latin America, the Middle East and Africa.
The global Acid Citrate Dextrose (ACD) Tubes market was valued at US$ million in 2020 and is expected to reach US$ million by the end of 2027, growing at a CAGR of % during 2021-2027.
This report focuses on Acid Citrate Dextrose (ACD) Tubes volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Acid Citrate Dextrose (ACD) Tubes market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Acid Citrate Dextrose (ACD) Tubes Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
6.0 mL
8.5 mL
Segment by Application
Hospitals
Diagnostics Centers
Health Care Clinics
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Fisher Scientific UK
Becton Dickinson
Cryoquip LLC.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.